External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study-Reference-Cited by-同舟云学术

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

Published:2013-02 Issue:2 Volume:14 Page:141-148
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Heng Daniel YC,Xie Wanling,Regan Meredith M,Harshman Lauren C,Bjarnason Georg A,Vaishampayan Ulka N,Mackenzie Mary,Wood Lori,Donskov Frede,Tan Min-Han,Rha Sun-Young,Agarwal Neeraj,Kollmannsberger Christian,Rini Brian I,Choueiri Toni K

Publisher

Elsevier BV

Subject

Oncology

Reference24 articles.

1. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

2. Sorafenib in advanced clear-cell renal-cell carcinoma;Escudier;N Engl J Med,2007

3. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial;Escudier;Lancet,2007

4. Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206;Rini;J Clin Oncol,2010

5. A randomized, double-blind phase III study of pazopanib in treatment-naive and cytokine-pretreated patients with advanced renal cell carcinoma (RCC);Sternberg;Proc Am Soc Clin Oncol,2009

Cited by 781 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. More Drugs Versus More Data: The Tug of War on Cancer in Low- and Middle-Income Countries;Hematology/Oncology Clinics of North America;2024-02

2. Locoregional Therapies in Immunologically “Cold” Tumors: Opportunities and Clinical Trial Design Considerations;Journal of Vascular and Interventional Radiology;2024-02

3. Risk of isolated metastatic disease outside the abdomen is low in cT1a renal cancer: A retrospective analysis of a large cohort from the Scottish Renal Cancer Consortium;Journal of Clinical Urology;2024-01-31

4. A promising natural killer cell-based model and a nomogram for the prognostic prediction of clear-cell renal cell carcinoma;European Journal of Medical Research;2024-01-24

5. Clear cell renal cell carcinoma: immunological significance of alternative splicing signatures;Frontiers in Oncology;2024-01-15